[1] 张悦民, 王剑飚.阿米卡星在1 例多抗凝药依赖性假性血小板减少症中的应用研究[J].诊断学理论与实践,2015,14(5):437-440.
[2] 宋延荣,张 萍.阿米卡星在假性血小板减少中的作用分析[J].实用医技杂志,2015,22(4):397-398.
[3] 张 莉.阿米卡星在EDTA依赖性假性血小板减少的探讨[J].国际检验医学杂志,2017,38(2):269-270.
[4] 王霄霞.外周血细胞形态学检查技术[M].北京:人民卫生出版社,2010:45.
[5] Gowland E, Kay H E, Spillman J C, et al. Agglutination of platelets by a serum factor in the presence of EDTA[J]. J Clin Pathol,1969,22(4):460-464.
[6] Lin J, Luo Y, Yao S, et al. Discovery and correction of spurious low platelet counts due to EDTA-dependent pseudothrombocytopenia[J]. J Clin Lab Anal, 2015,29(5):419-426.
[7] Payman B B,Daniel G,Nadine S,et al. Impact of amikacin on pseudothrombocytopenia[J].Acta Haematol,2017,137(1):27-29.
[8] Sakurai S,Shiojima I,Taniqawa T,et al.Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia[J].Br J Haematol,1997,99(4):817-823.
[9] Zhou X, Wu X, Deng W, et al. Amikacin can be added to blood to reduce the fall in platelet count[J]. Am J Clin Pathol,2011,136(4):646-652.